Coverage
-
June 02, 2026
Eli Lilly & Co. cited two circuit opinions this week as it defended the legality of halting the flow of discounted drugs under the 340B pricing program for safety net hospitals that won't hand over claims data. Law360 takes a closer look at the cases and decisions Eli Lilly is relying on.
5 other articles on this case.
View all »